Oral administration of Bifidobacterium longum ES1 reduces endometrial inflammation in women with recurrent pregnancy loss
- 6 December 2023
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 91 (1) , e13804
Abstract
Background: Over‐activation of endometrial inflammasome NALP‐3 (Nod‐like receptor family pyrin domain containing 3) can be found in recurrent pregnancy loss (RPL) women probably due to leaky gut and passage into circulation of lipopolysaccharides (LPS). Leaky gut can be caused by exposure to gluten in RPL women genetically predisposed to celiac disease, positive for Human Leukocyte Antigen (HLA)‐DQ2/DQ8 haplotype. Oral administration of Bifidobacterium longum ES1 (GliadinES®) can inactivate gluten peptides toxicity to epithelial gut cells and improve gut barrier.Methods: We investigated by enzyme‐linked immunoassay: (a) serum levels of LPS and zonuline (a marker of leaky gut); (b) LPS, NALP‐3, caspase‐1, interleukine (IL)‐1β and IL‐18 concentration in endometrial fluids, in untreated women with uncomplicated pregnancies (negative HLA‐DQ2/DQ8 haplotype) (n = 22) and in women with unexplained RPL, HLA‐DQ2/DQ8 positive (n = 22), before and after daily oral administration for 3 months of GliadinES®.Results: RLP women showed higher serum levels of LPS (p < 0.0001) and higher concentration of LPS (p < 0.0001), NALP‐3 (p < 0.01); Caspase‐1 (p < 0.0001), IL‐1β (p < 0.0001), and IL‐18 (p < 0.0001) in endometrial fluids compared to controls. GliadinES® treatment significantly reduced serum levels of both LPS (p < 0.0001) and zonuline (p < 0.01), as well as LPS (p < 0.5), NALP‐3 (p < 0.01), Caspase‐1 (p < 0.001), IL‐1β (p < 0.001), and IL‐18 (p < 0.01) concentrations in endometrial fluids of RPL women.Conclusions: RPL women positive for HLA‐DQ2/DQ8 haplotype show increased circulating and endometrial levels of LPS and endometrial inflammasome NALP‐3 over‐activation. Oral administration of GliadinES® can reduce gut permeability, decrease serum levels of LPS and, contextually, improve endometrial inflammation in this specific subset of RPL women.Keywords
This publication has 20 references indexed in Scilit:
- Inflammosome in the human endometrium: further step in the evaluation of the “maternal side”Fertility and Sterility, 2016
- Time to conception and time to live birth in women with unexplained recurrent miscarriageHuman Reproduction, 2014
- Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanismsHuman Reproduction Update, 2014
- Potential New Mechanisms of Placental Damage in Celiac Disease: Anti-Transglutaminase Antibodies Impair Human Endometrial Angiogenesis1Biology of Reproduction, 2013
- Bifidobacterium longum CECT 7347 Modulates Immune Responses in a Gliadin-Induced Enteropathy Animal ModelPLOS ONE, 2012
- Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestionJournal of Cellular Biochemistry, 2010
- Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patientsJournal of Inflammation, 2008
- Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell linesScandinavian Journal of Gastroenterology, 2006
- Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposureGastroenterology, 2002
- Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac diseaseThe Lancet, 2000